![]()
- Thanksgiving Week Stuffed With Economic News
- First Senate Vote Looms on Health Legislation
- Black Friday Deals May Not Signal Retail Comeback
- Victoria's Secret Hopes to Rekindle Desire for Lingerie
- UPS Sets New Rates For 2010
- Wall Street Jobs Slow to Return Despite Record Profits
- Investors to Goldman: Be Less Greedy
- Senate Panel to Mull Bernanke Nomination On Dec. 3
- $6M Verdict Upheld in McDonald's Strip Search Case
- How Stock Investors Can Play Holiday Travel
- Time Lapse World Series Is A Great Play
- Hirschhorn: Greed...or Fear
- My Top 10 Tech Toys for the Holidays
- iPhone a Better Gaming Platform Than Android?
- May Day For Dendreon
- 100% Mortgage Financing From USDA
- Holiday Tipping: Who And How Much
- Deep Discounts Should Make It a Very Tech-y Holiday
MOST SHARED
- Nielsen Ratings Coming to Video Games
- The Week Ahead
- Oil Next Week
- Time Lapse World Series Is A Great Play
- Bove: Expect Goldman To Increase Dividend Meaningfully
- Realty Check: USDA Home Loans
- Hershey Mulls $17 Billion Bid for Cadbury: Source
- Hot Topics at TEDMED
- Lightning Round OT: Knight Capital, Ebix and More
Writer
Stocks posted their biggest declines since Oct. 1 on Wednesday as worries about the recovery gripped the market.
The Dow Jones Industrial Average shed 119.48, or 1.2 percent, to close at 9,762.69. The S&P 500 lost 2 percent and Nasdaq dropped 2.7 percent.
The CBOE volatility index, widely considered the best gauge of fear, jumped to just shy of 28. The gauge had been inching toward 20 before the recent selloff.
The data today backed up those fears: New-home sales dropped 3.6 percent in September and August's gain was revised lower. Economists had expected sales to rise. That piled on to the bad news for the housing sector after an earlier report showed mortgage applications fall for the third week in a row last week.
And Goldman Sachs slashed its forecast for third-quarter GDP to 2.7 percent from 3 percent. The government's first read on Q3 GDP is due out on Thursday.
Investors shrugged off a report that showed durable-goods orders rose 1 percent in September, though compared to last year fell more than 24 percent.
Financials and materials were among the day's biggest decliners as the dollar strengthened.
Alcoa [AA
Loading...
()
], Caterpillar [CAT
Loading...
()
] and Intel [INTC
Loading...
()
] were the biggest drags on the Dow. Telecoms AT&T [T
Loading...
()
] and Verizon [VZ
Loading...
()
] were at the top of the pack.
Oil fell, settling at $77.46 a barrel, after a report showed crude inventories rose by just 778,000 barrels last week. Economists had expected a 1.7 million build. Gold dropped nearly $5, settling at $1,029.90 a troy ounce.
The Treasury's five-year auction today was met with decent demand but it wasn't as strong as the other auctions this week. Tomorrow is the seven-year auction.
Investors also shrugged off some earnings beats: ConocoPhillips [AIG
Loading...
()
] reported a sharp drop in earnings and revenue from a year earlier but still beat expectations.
Visa [AIG
Loading...
()
] beat on both earnings and revenue with its results after the bell Tuesday, and raised its dividend.
The tech-heavy Nasdaq was the hardest hit of the three indexes, down 2.7 percent, as investors have begun to unwind some of their recovery trades in tech and consumer discretionary. Those sectors were among the hardest hit in yesterday's session.
Intel [INTC
Loading...
()
] lost 3.6 percent, Apple [AAPL
Loading...
()
] dropped 2.5 percent and Microsoft [MSFT
Loading...
()
] shed 2 percent.
Verizon [VZ
Loading...
()
] and Motorola [MOT
Loading...
()
] advanced as the pair debuted their new phone that uses Google's [GOOG
Loading...
()
] Droid software. The phone goes on sale Nov. 6, priced at about $200 after rebate.
Garmin [GRMN
Loading...
()
] fell a whopping 16 percent as the Google phone also includes a free app for GPS navigation, Gizmodo reports.
The Nasdaq is now lower for October, though the Dow and S&P 500 are still higher for the month.
![]() |
A tale of two IPOs today: Vitamin Shoppe shares [VSI
Loading...
()
] soared 6 percent after the vitamin chain's IPO priced above expectations. It's the first retailer to go public in two years. But Addus Homecare [ADUS
Loading...
()
] fell more than 15 percent in its debut on the Nasdaq after pricing below expectations.
Apollo Group [APOL
Loading...
()
] dragged on the Nasdaq, tumbling 18 percent, as federal regulators opened a probe into the educational group's accounting and at least three brokerages downgraded the stock.
AstraZeneca [AZN-LN Loading... ()] shares fell 1.5 percent as the company pulled its experimental lung-cancer drug Zactima from the regulatory submission process, after the drug demonstrated no survival advantage when added to chemotherapy.
Still to Come:
THURSDAY: 80th anniversary of 1929 market crash; Weekly jobless claims; first look at Q3 GDP; Larry Summers speaks in NYC; Earnings from AstraZeneca, ExxonMobil, P&G, Aetna, Kellogg, Motorola and Sprint Nextel
FRIDAY: Personal income and spending; consumer sentiment; Earnings from Chevron
Send comments to .
- Technology can make or break a fortune in the world of alternative energy.
- Many people are facing the holidays with substantially smaller incomes. Here’s how some are adapting.
- Jim Cramer is a proponent of stocks that pay healthy dividends, and here are his top five dividend plays.
- From salt, to lip balm to envelopes, it turns out that bacon flavoring can sell almost anything.
- The homebuyer's tax credit jacked sales for a while, but 2010 is looking weak. Now what?
- CNBC’s technology reporter Jim Goldman guides you through the best gadgets to buy this holiday season.














